Mortality and Economic Impact of Heart Failure

Area of Science:

• Cardiology
• Public Health
• Health Economics

Background:

• Heart failure (HF) mortality rates have been increasing in the US since 2012.
• Disproportionate increases are observed in individuals under 65 and those identifying as Black.
• Existing HF therapies are effective but costly.

Purpose of the Study:

• To analyze mortality risk from heart failure.
• To evaluate the costs and cost-effectiveness of contemporary HF therapies.
• To inform strategies for combating the HF epidemic.

Main Methods:

• Mortality data analysis.
• Cost-effectiveness modeling.
• Guideline-endorsed therapy review.

Main Results:

• Rising HF mortality trends identified.
• Significant cost implications of advanced therapies noted.
• Need for cost-effectiveness data highlighted.

Conclusions:

• Addressing the HF epidemic requires understanding mortality risks.
• Balancing therapy effectiveness with patient and payer costs is essential.
• Further research into cost-effectiveness is critical for optimal HF management.